MedTrace Logo

Primary HPV Self-Collection in Indonesia

NCT06942286 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8000

Last updated 2025-09-17

No results posted yet for this study

Summary

The purpose of this study is to implement human papillomavirus (HPV) self-collection in Indonesia.

Conditions

  • Cervical Cancers
  • CIN - Cervical Intraepithelial Neoplasia
  • Human Papillomavirus (HPV)

Interventions

DIAGNOSTIC_TEST

HPV Self-Collection

Participants will perform HPV self-collection.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Dharmais National Cancer Center Hospital

    lead OTHER_GOV

Principal Investigators

  • Widyorini L Hanafi, MD · Dharmais National Cancer Center Hospital

  • Dian T Sinulingga, MD, M.Epid · Dharmais National Cancer Center Hospital

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
69 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-13
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06942286 on ClinicalTrials.gov